News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Agios Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
FDA
Agios, Celgene Win Early FDA Approval for New Cancer Drug
August 1, 2017
·
2 min read
Drug Development
Cambridge Biotech Agios Terminates AG-519 for PK Deficiency, But Continues AG-348 For Same Condition
December 16, 2016
·
2 min read
FDA
Another Celgene Bet Pays Off as Agios Eyes Early Approval of Leukemia Drug
September 7, 2016
·
2 min read
Business
Former BIND Therapeutics CEO Joins Agios as New CFO
August 16, 2016
·
2 min read
Business
Agios, Celgene Hammer Out $1 Billion+ Metabolic Immuno-Oncology Deal
May 18, 2016
·
3 min read
Genetown
10 Massachusetts Biotechs Devoting the Most Cash to R&D
May 5, 2016
·
3 min read
Genetown
Celgene And Agios Deliver Some Great “Bad” News
June 18, 2015
·
1 min read
Business
Celgene Dealmaking Continues With Two Pacts Worth $110 Million With Agios, Northern Biologics
April 29, 2015
·
3 min read
Genetown
Citi: Agios Pharmaceuticals’s Experimental Cancer Drug Could Provide Major Upside
November 10, 2014
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Genetown
Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023
August 29, 2023
·
1 min read
Business
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
August 3, 2023
·
10 min read
Genetown
Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera
August 3, 2023
·
7 min read
Drug Development
Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin Response
June 26, 2023
·
11 min read
Genetown
Agios to Present at the Goldman Sachs Global Healthcare Conference on June 15, 2023
June 5, 2023
·
1 min read
Genetown
Agios to Present Clinical and Translational Data at European Hematology Association Annual Congress
May 11, 2023
·
8 min read
Business
Agios Reports Business Highlights and First Quarter 2023 Financial Results
May 4, 2023
·
9 min read
Genetown
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 16, 2023
April 25, 2023
·
1 min read
Business
Agios Appoints Jeffrey Capello to Board of Directors
April 19, 2023
·
6 min read
Business
Agios to Webcast Conference Call of First Quarter 2023 Financial Results on May 4, 2023
April 13, 2023
·
1 min read
